- Home
- KRYS vs QRVO Comparison
KRYS vs QRVO Comparison
Compare KRYS & QRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRYS | QRVO |
|---|---|---|
| Founded | 2015 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 8.1B |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | KRYS | QRVO |
|---|---|---|
| Price | $259.27 | $78.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 12 |
| Target Price | ★ $297.60 | $90.55 |
| AVG Volume (30 Days) | 260.4K | ★ 1.0M |
| Earning Date | 05-18-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 128.00 | ★ 180.56 |
| EPS | ★ 6.84 | 3.30 |
| Revenue | $389,130,000.00 | ★ $3,718,971,000.00 |
| Revenue This Year | $40.88 | $0.81 |
| Revenue Next Year | $35.16 | N/A |
| P/E Ratio | $37.15 | ★ $23.55 |
| Revenue Growth | ★ 33.94 | N/A |
| 52 Week Low | $123.03 | $49.46 |
| 52 Week High | $298.30 | $106.29 |
Technical Indicators
Market Signals| Indicator | KRYS | QRVO |
|---|---|---|
| Relative Strength Index (RSI) | 44.51 | 36.06 |
| Support Level | $255.65 | $75.71 |
| Resistance Level | $293.60 | $79.13 |
| Average True Range (ATR) | 11.12 | 1.98 |
| MACD | -2.10 | -0.53 |
| Stochastic Oscillator | 20.44 | 28.39 |
Price Performance
Historical ComparisonAbout KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.